Avantor (NYSE:AVTR) Director Simon Dingemans Purchases 25,000 Shares of Stock

Avantor, Inc. (NYSE:AVTR) Director Simon Dingemans acquired 25,000 shares of the business’s stock in a transaction on Friday, May 1st. The shares were bought at an average cost of $8.14 per share, with a total value of $203,500.00. Following the completion of the acquisition, the director owned 25,000 shares in the company, valued at approximately $203,500. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Avantor Stock Up 0.7%

NYSE AVTR opened at $8.05 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. The company has a market capitalization of $5.49 billion, a P/E ratio of -9.93, a P/E/G ratio of 4.66 and a beta of 0.94. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93. The stock has a 50 day moving average price of $8.12 and a 200-day moving average price of $10.41.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.23 EPS. As a group, equities analysts predict that Avantor, Inc. will post 0.79 EPS for the current fiscal year.

Institutional Trading of Avantor

A number of hedge funds have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC grew its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the last quarter. Private Trust Co. NA grew its stake in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor in the second quarter valued at about $32,000. Los Angeles Capital Management LLC purchased a new position in Avantor in the fourth quarter valued at about $32,000. Finally, Osaic Holdings Inc. grew its stake in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of research reports. Evercore set a $10.00 target price on Avantor in a research report on Wednesday, February 11th. Wells Fargo & Company lowered their target price on Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Robert W. Baird set a $11.00 target price on Avantor in a research report on Thursday, February 12th. Citigroup lowered their target price on Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Finally, Stifel Nicolaus set a $10.00 target price on Avantor in a research report on Thursday, February 12th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $11.39.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.